Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kallyope
AddedFeb 13, 2024
UpdatedJun 18, 2026
Kallyope

Kallyope

Series A

NY-based Kallyope develops an industry-leading platform to harness the gut-brain axis.

HQ
New York City, NY, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded and headquartered in New York City, Kallyope is committed to developing an industry-leading platform to harness the gut-brain axis. The company's core mission is to discover and develop novel, oral, small-molecule therapeutics that address significant health challenges, particularly in metabolic, neurological, and gastrointestinal diseases. By focusing on these areas, Kallyope aims to create effective, easy-to-use, and well-tolerated treatments that can significantly improve patient outcomes.

Kallyope has attracted notable affiliated people and investors, including prominent figures in biotechnology and venture capital. The company has made key achievements in advancing its therapeutic pipeline, with several promising candidates in various stages of development. Through its innovative approach to the gut-brain axis, Kallyope has the potential to make a substantial impact on the treatment of complex diseases, positioning itself as a leader in the biotech industry.

Kallyope - Similar Companies

Bloom Science logo

Bloom Science

bloomscience.com

Kalypsys logo

Kalypsys

kalypsys.com

Enterin logo

Enterin

enterininc.com

Axial Therapeutics logo

Axial Therapeutics

Petri Bio logo

Petri Bio

petribio.com

Bryleos logo

Bryleos

bryleos.com

Woven Science logo

Woven Science

woven.science

Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Neuraly logo

Neuraly

neuralymed.com

Intact Therapeutics logo

Intact Therapeutics

Halia Therapeutics logo

Halia Therapeutics

Holobiome logo

Holobiome

holobiome.org

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Elysium Health logo

Elysium Health

elysiumhealth.com

Kallyope - Quick Facts

Who are Kallyope's competitors?

Companies similar to Kallyope include Bloom Science, Kalypsys, Enterin and Axial Therapeutics.

When was Kallyope founded?

Kallyope was founded in 2015.

Where is Kallyope's headquarters located?

Kallyope's headquarters is located in New York City, NY, US.

When was Kallyope's last funding round?

Kallyope's most recent funding round was for $8.2M (USD) in May 2023.

How much has Kallyope raised to-date?

As of May 10, 2023, Kallyope has raised a total of $487.2M (USD).

How many employees does Kallyope have?

Kallyope has 108 employees as of Feb 5, 2024.

Kallyope - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified